Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases

The current therapies based on immunosuppressant or new biologic drugs often show some limitations in term of efficacy and applicability, mainly because of their inadequate targeting and of unwanted adverse reactions they generate. To overcome these inherent problems, in the last decades, innovative...

Descripción completa

Detalles Bibliográficos
Autores principales: Talamini, Laura, Matsuura, Eiji, De Cola, Luisa, Muller, Sylviane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004653/
https://www.ncbi.nlm.nih.gov/pubmed/33806746
http://dx.doi.org/10.3390/cells10030707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004653/
https://www.ncbi.nlm.nih.gov/pubmed/33806746
http://dx.doi.org/10.3390/cells10030707

Ejemplares similares